U.S. Paper and Forestry Products Stock News

On November 6, 2025, Collegium Pharmaceutical reported its third quarter results, delivering a significant year-over-year increase in net income to US$31.51 million and raising its full-year 2025 net product revenue guidance to a range of US$775–785 million. While third quarter earnings outpaced the prior year substantially, the company's net income for the first nine months declined compared to the same period in 2024, highlighting variability across reporting periods. We'll explore how...

Gorman-Rupp (GRC) announced its third quarter results, reporting sales growth but a dip in quarterly net income compared to last year. The company also revealed a 2.7% increase in its quarterly dividend, a move that often draws investor attention. See our latest analysis for Gorman-Rupp. Gorman-Rupp’s solid 8.96% share price return over the past 90 days suggests building momentum, supported by its stronger year-to-date and three-year total shareholder returns. The market appears to be...

Aurinia Pharmaceuticals recently raised its full-year 2025 revenue and net product sales guidance following strong third-quarter financial results, with total revenue reaching US$73.47 million and net income climbing to US$31.55 million. This update reflects both increased demand for its lupus nephritis therapy LUPKYNIS and improved operational efficiency stemming from recent restructuring initiatives. We'll examine how management’s raised revenue guidance and improved product sales impact...

Choice Hotels International (CHH) reported strong third quarter results, with record adjusted EBITDA and a sharp increase in profit. The company's momentum comes largely from global expansion, higher franchise fees, and the completion of the Choice Hotels Canada acquisition. See our latest analysis for Choice Hotels International. Despite hitting record profitability on global expansion and lifting its earnings outlook, Choice Hotels International’s momentum has not yet translated to the...

Dianthus Therapeutics recently reported its third quarter 2025 earnings, showing revenue of US$396,000 and a net loss of US$36.77 million, while also presenting new Phase 2 MaGic trial data for claseprubart in generalized Myasthenia Gravis at major industry forums. The Phase 2 results highlighted strong clinical responses and unique mechanistic insights, suggesting potential for less frequent dosing and reinforcing interest in the company's ongoing pipeline development despite financial...

Invesco (NYSE:IVZ) delivered a strong third quarter for 2025, posting sharp gains in both revenue and net income. Record assets under management and healthy net long-term inflows caught investor attention this season. See our latest analysis for Invesco. Invesco’s momentum has accelerated throughout 2025, with the share price climbing 32.5% year-to-date and a 34% total return over the past year. Recent headlines, including a dividend affirmation, a large-scale buyback update, strategic...

SailPoint (SAIL) shares have delivered mixed performance lately, with the price up almost 4% in the past 3 months but still down nearly 9% year to date. Investors might be weighing recent financial results and growth potential as they consider next steps. See our latest analysis for SailPoint. SailPoint’s share price has seen some swings lately, with the 7-day and 30-day share price returns each slipping over 7%. However, the 3-month share price return remains positive. The recent pattern...

Earlier this week, Workiva Inc. reported third-quarter 2025 results with revenue rising to US$224.17 million and a swing to net income of US$2.79 million from a net loss a year ago, while also raising its full-year guidance and appointing Michael Pinto as Chief Revenue Officer. The combination of strong revenue momentum, improved profitability, and a key executive hire reflected growing demand for Workiva's cloud-based and AI-powered reporting platform. We'll explore how the company's raised...

Symbotic recently reported quarterly revenues that exceeded analyst estimates by over 10%, reflecting robust demand for its automation technology and warehouse solutions. Despite a negative earnings per share surprise, analysts remain focused on the company's strong revenue performance and expectations for significant year-over-year earnings growth. We'll explore how Symbotic's revenue beat supports the company's long-term growth outlook and affects its overall investment narrative. Uncover...

Vera Therapeutics reported results for the third quarter and nine months ended September 30, 2025, posting a net loss of US$80.29 million for the quarter and US$208.52 million for the nine-month period, both substantially higher than the same periods last year. The wider losses signal rising expenses or investments, which may be drawing greater scrutiny to the company’s financial trajectory and resource allocation. Given these significantly increased losses, we'll examine how the earnings...

Earlier this week, Euronet Worldwide reported strong momentum in its Money Transfer segment, reflecting continued demand for its diverse electronic payment solutions across multiple markets. An important takeaway is that Euronet's ongoing expansion into emerging markets and its digital transformation projects are fueling optimism despite increased regulatory and compliance demands. We will now explore how the robust performance of Euronet's Money Transfer segment may influence its broader...

Earlier this week, First Merchants Chief Information Officer Stephan Fluhler sold 5,689 shares of company stock after the company released third-quarter earnings that beat profit forecasts but missed on revenue expectations. This combination of mixed results and insider share sale may prompt questions about the company's growth outlook and executive confidence. We'll explore how the revenue miss and executive stock sale could impact First Merchants' longer-term investment narrative. The...

UFP Technologies (UFPT) just released its third-quarter earnings, delivering both higher sales and adjusted earnings per share than market forecasts. Revenue climbed from the previous year, and management highlighted steady execution on strategic goals. See our latest analysis for UFP Technologies. The upbeat results arrived as UFP Technologies’ share price has seen a sharp rebound this past week, posting a 20% seven-day gain after earlier declines in 2024. While the total shareholder return...

Earlier this week, Viridian Therapeutics reported third quarter earnings for 2025, highlighting a sharp rise in revenue to US$70.57 million and a reduced net loss of US$34.6 million, as well as announcing the submission of a Biologics License Application (BLA) to the FDA for veligrotug, its investigational therapy for thyroid eye disease, supported by positive phase 3 clinical data. This dual milestone not only advances Viridian's lead program toward potential commercial launch, but also...

Perimeter Solutions announced third quarter and nine-month 2025 results, highlighting an increase in sales to US$315.44 million and a reduction in net losses for the year-to-date period, despite continued operational challenges and litigation in its Specialty Products segment. Securing a new contract with the US Forest Service and expanding its Fire Safety operations internationally have positioned the company to enhance its presence in both domestic and global markets. We’ll explore how the...

Claritev Corporation recently announced a partnership involving a strategic investment in Klaim Inc., an AI-based healthcare payment-acceleration provider, to launch a co-branded Payment Acceleration Service integrated within Claritev's provider network across the U.S. and MENA regions. This collaboration is set to reduce healthcare providers' reimbursement times by converting pending insurance claims into near-instant liquidity, broadening market access and operational efficiency for both...

The Mosaic Company recently reported its third-quarter 2025 earnings, posting sales of US$3.45 billion and net income of US$411.4 million, both well above figures from the previous year. This sharp increase in profitability reflects significant operational improvement despite ongoing industry challenges, positioning Mosaic as a key performer within the fertilizer sector. We'll examine how Mosaic's strong quarterly earnings performance influences the company's longer-term investment outlook...

Littelfuse (LFUS) released its third quarter earnings, highlighting year-over-year gains in both sales and net income. The company also offered updated revenue guidance for next quarter and confirmed a cash dividend for shareholders. See our latest analysis for Littelfuse. Littelfuse’s latest results show the company building on solid fundamentals, but the share price hasn’t kept pace. Its 1-year total shareholder return is down 5.8%, while the stock is up just 2.8% year-to-date. Recent...

Sportradar Group (NasdaqGS:SRAD) attracted attention after announcing its third quarter 2025 results, which showed higher sales compared to last year and highlighted continued growth in the company’s main business segments. See our latest analysis for Sportradar Group. Sportradar Group’s recent results landed just after news of its IMG ARENA acquisition, which significantly expanded its sports content portfolio and global reach. This move may have shifted some investor sentiment. Despite a...

Provident Financial Services, Inc. recently reported strong third quarter 2025 results, including net income of US$71.72 million and a quarterly cash dividend declaration of US$0.24 per share, alongside updates on its ongoing share repurchase program. The company also posted reduced net loan charge-offs compared to a year ago, indicating improvements in asset quality and credit performance. With these positive earnings and asset quality developments, we'll explore how the earnings...

Inter & Co recently announced the launch of its operations in Argentina, aiming to attract Argentine customers seeking to invest in the US as part of its broader international expansion beyond Brazil. This move reflects Inter & Co's commitment to positioning itself as a regional digital banking player by directly addressing demand from investors in key Latin American markets. We'll explore how Inter & Co's entry into Argentina could enhance its investment narrative by expanding its...

Ascendis Pharma recently presented three-year clinical data at Kidney Week 2025, highlighting sustained improvements in renal function and normalization of urine calcium handling in adults with hypoparathyroidism treated with TransCon PTH (YORVIPATH). This long-term data strengthens the safety and efficacy profile of TransCon PTH and may enhance its positioning in global kidney health discussions. We'll explore how these positive long-term results for TransCon PTH may influence Ascendis...

Cadre Holdings reported strong third quarter 2025 results last week, with sales rising to US$155.87 million and net income reaching US$10.94 million, both up substantially from a year earlier. The company’s earnings per share nearly tripled compared to the same quarter in 2024, highlighting meaningful operational improvement and earnings growth. We will examine how this surge in both revenue and profit could shape Cadre Holdings' investment narrative and near-term outlook. Rare earth metals...

ResMed (RMD) has caught investor attention following its Q1 results, which showed steady growth in both revenue and net income. The stock pulled back slightly, but longer-term sentiment remains constructive. See our latest analysis for ResMed. ResMed’s share price has pulled back in recent weeks after an earlier rally, reflecting a mix of excitement from strong Q1 financials and some short-term profit-taking. Over the past year, the total shareholder return sits just above break-even. Looking...